Relations (1)
related 2.00 — strongly supporting 3 facts
Mystical experiences are being investigated as a therapeutic intervention for depression, as evidenced by the correlation between the intensity of these experiences and positive psychological outcomes [1]. Psilocybin is specifically noted for its potential to facilitate these breakthroughs to treat depression [2], while the emotional profile of such experiences contrasts with the negative emotional states often associated with depression [3].
Facts (3)
Sources
The Mechanisms of Psychedelic Visionary Experiences - Frontiers frontiersin.org 1 fact
claimPsychedelic and mystical experiences typically involve positive emotions such as happiness and bliss, while negative emotions appear less central, potentially because depression is not an adaptive response.
The Montreal model: an integrative biomedical-psychedelic ... frontiersin.org 1 fact
claimPsilocybin currently has stronger evidence than ketamine supporting the therapeutic potential of 'emotional breakthroughs' and mystical experiences in the treatment of depression.
Medicinal plants meet modern biodiversity science - OUCI ouci.dntb.gov.ua 1 fact
claimNumerous studies indicate a direct correlation between the strength of peak and mystical experiences and positive, long-lasting psychological outcomes in psychedelic psychotherapy for conditions including depression, cancer-related distress, and substance use disorders.